Comhábhair Ghníomhach Cógaisíochta
| Progestogen agus estrogen | |||
| Ainm Táirge | Sonraíocht | Ceadaithe | CAS Uimh. |
| Progesterone | CP/PE/USP/JP | CEP/EU-GMP/FDA | 57-83-0 |
| Pregnenolone | In-tí |
Kosher | 145-13-1 |
| Medroxyprogesterone Aicéatáit | CP/PE/USP/JP | DMF/GMP | 71-58-9 |
| Aicéatáit Megestrol | CP/PE/USP | DMF i bpróiseas | 595-33-5 |
| Mifepristone | CP/IP | DMF/GMP | 84371-65-3 |
| Aicéatáit Cyproterone | CP/PE/IP/KP | CEP/TGA/EU-GMP | 427-51-0 |
| Levonorgestrel | CP/PE/USP/IP | CEP/GMP | 797-63-7 |
| Norethisterone |
CP/PE/USP/JP |
DMF i bpróiseas |
68-22-4 |
| Aicéatáit Norethisterone |
EP/USP |
DMF i bpróiseas |
51-98-9 |
| Norethisterone Enanthate |
In-tí |
Faoi T&F |
3836-23-5 |
| Drospirenone | EP/USP | DMF | 67392-87-4 |
| Gestóidéin | CP/PE | DMF/GMP | 60282-87-3 |
| Estradiol | CP/PE/USP/KP | DMF/GMP/WC | 35380-71-3 |
| Estriol | CP/PE/USP | Faoi T&F | 50-27- 1 |
| Ethinyl Estradiol | CP/PE/USP | GMP | 57-63-6 |
| Valerate Estradiol | CP/PE/USP/KP | DMF | 979-32-8 |
| Estradiol Cypionate |
USP | DMF i bpróiseas |
313-06-4 |
| Promestrene |
In-tí |
Faoi T&F |
39219-28-8 |
| Tibolone | CP/PE | DMF/GMP | 5630-53-5 |
| Dienogest | PE | CEP/GMP | 65928-58-7 |
| Fulvestrant | EP/USP | Faoi T&F | 129453-61-8 |
| Exemestane | CP/PE/USP | Faoi T&F | 107868-30-4 |
| Androgen | |||
| Ainm Táirge | Sonraíocht | Ceadaithe | CAS Uimh. |
| Finasteride | CP/PE/USP | CEP/FDA/PMDA/GMP | 98319-26-7 |
| Dutasteride | EP/USP | CEP/FDA | 164656-23-9 |
| Aicéatáit Abiraterone | CP/USP | DMF/GMP/WC | 154229-18-2 |
| Darolutamide |
In-tí |
Faoi T&F |
1297538-32-9 |
| Testosterone | CP/PE/USP | CEP/FDA/WC | 58-22-0 |
| Testosterone Undecanoate | CP | DMF/WC | 5949-44-0 |
| Testosterone Cypionate | USP | DMF | 58-20-8 |
| Testosterone Enanthate |
USP/JP | Faoi T&F |
315-37-7 |
| Testosterone Propionate |
CP/PE/USP/JP |
Faoi T&F |
57-85-2 |
| DHEA | FP/In-tí | DMF/WC/Kosher | 53-43-0 |
| Clascoterone | In-tí | DMF i bpróiseas | 19608-29-8 |
| Hormone Cortical | |||
| Ainm Táirge | Sonraíocht | Ceadaithe | CAS Uimh. |
| Budesonide | CP/PE/USP/JP | CEP/FDA/GMP | 51333-22-3 |
| Desonide | CP/USP | DMF/GMP | 638-94-8 |
| Eplerenone | PE | CEP ar siúl | 107724-20-9 |
| Methylprednisolone | CP/PE/USP/JP | DMF/GMP | 83-43-2 |
| Methylprednisolone Hemisuccinate | CP/PE/USP | DMF/GMP | 2921-57-5 |
| Fluticasone Propionate | CP/PE/USP | DMF | 80474- 14-2 |
| Fluticasone Furoate | CP/PE | DMF i bpróiseas | 397864-44-7 |
| Mometasone Furoate |
CP/PE/USP |
DMF i bpróiseas |
Ainhidriúil (83919-23-7) Monahiodráit (141646-00-6) |
| Deflazacort |
In-tí |
Faoi T&F |
14484-47-0 |
| Daoine eile | |||
| Ainm Táirge | Sonraíocht | Ceadaithe | CAS Uimh. |
| Oxcarbazepine | CP/PE/USP/IP | CEP/FDA/GMP | 28721-07-5 |
| Aicéatáit Eslicarbazepine | CP/USP | DMF | 236395- 14-5 |
| Ganciclovir | CP/PE/USP | DMF/GMP | 82410-32-0 |
| Valganciclovir Hidreaclóiríd | USP/EP | CEP ar siúl | 175865-59-5 |
| Fosfáit Oseltamivir | CP/PE/USP | DMF | 204255- 11-8 |
| Baloxavir Marboxil | In-tí | Faoi T&F | 1985606-14-1 |
| Revefenacin | In-tí | DMF | 864750-70-9 |
| Mireabóg | CP/PE | DMF | 223673-61-8 |
| Vibegron |
In-tí |
Faoi T&F |
1190389-15-1 |
| Escitalopram Oxalate | CP/PE/USP | DMF i bpróiseas | 219861-08-2 |
| Citalopram Hidreabrómide |
CP/PE/USP |
DMF i bpróiseas |
59729-32-7 |
| Hidreaclóiríd Cariprazine | In-tí | DMF | 1083076-69-0 |
| Lasmiditan Succinate | In-tí | DMF | 439239-92-6 |
| Luliconazole | In-tí | DMF | 187164-19-8 |
| Esylate Nintedanib |
In-tí |
FDA/DMF/WC |
656247-18-6 |
| Apalutami | In-tí | DMF | 956104-40-8 |
| Tadalafil | CP/PE/USP | Faoi T&F | 171596-29-5 |
| Relugolix | In-tí | DMF i bpróiseas | 737789-87-6 |
| fosfáit ruxolitinib |
In-tí |
DMF i bpróiseas |
1092939-17-7 |
| Abemaciclib |
In-tí |
Faoi T&F |
1231929-97-7 |
| Phloroglucinol | CP/PE | DMF | 108-73-6 |
| 1,3,5-Trimethoxybenzene |
CP/In-tí |
GMP |
621-23-8 |
| Aigéad Ursodeoxycholic | PE/USP/JP | Faoi T&F | 128-13-2 |
| Aigéad Tauroursodeoxycholic |
In-tí |
Faoi T&F |
14605-22-2 |
| Cholesterol |
CP/PE/USP/JP |
Faoi T&F |
57-88-5 |
| Éitear eitile Omega-3-Aigéad 90 |
EP/USP |
DMF i bpróiseas |
—— |
| Tríghlicrídí meánshlabhra |
CP/USP/EP |
DMF |
—— |
| Clóiríd Benzalkonium |
USP/EP/JP |
CEP ar siúl |
8001-54-5 |
| Ola olóige (Le Instealladh) |
CP/USP/PE/JP |
DMF i bpróiseas |
8001-25-0 |
| Fosfailipidí uibheacha (Le Instealladh) |
CP/USP/EP |
DMF |
93685-90-6 |
| Snack |
In-tí |
DMF i bpróiseas |
203787-91-1 |
Tá sonraíochtaí EP, USP, CP, JP, IP agus KP ar fáil ag Progesterone, faomhadh EU-GMP, FDA.
Tá sonraíochtaí EP, USP, CP, IP, JP ar fáil ag Finasteride, tá FDA, PMDA agus GMP ceadaithe.
Tá sonraíochtaí USP, EP ag Budesonide. CEP, GMP agus FDA ceadaithe.
Tá sonraíocht EP, USP, CP, IP, JP ag Dutasteride. CEP agus FDA ar fáil.
Tá sonraíochtaí USP agus EP ag Desonide. DMF ar fáil.
Tá sonraíochtaí USP, EP, IP, JP agus KP ag Methylprednisolone. DMF agus leithreas ar fáil.